Skip to main content
رجوع
LNTH logo

Lantheus Holdings, Inc.

جودة البيانات: 100%
LNTH
NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
KWD 75.73
▼ KWD 0.70 (-0.92%)
القيمة السوقية: 5.02B
نطاق اليوم
KWD 75.40 KWD 78.04
نطاق 52 أسبوعًا
KWD 47.25 KWD 108.91
حجم التداول
746,303
متوسط 50 يوم / 200 يوم
KWD 71.57 / KWD 65.11
الإغلاق السابق
KWD 76.43

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E 21.5 0.4
P/B 4.6 2.9
ROE % 21.5 3.7
Net Margin % 15.2 3.8
Rev Growth 5Y % 38.0 10.0
D/E 0.0 0.2

النقاط الرئيسية

Revenue grew 37.99% annually over 5 years — strong growth
Earnings declined -25.25% over the past year
ROE of 21.45% indicates high profitability
Net margin of 15.15% shows strong profitability
Debt/Equity of 0.00 — conservative balance sheet
Generating 354.05M in free cash flow

النمو

Revenue Growth (5Y)
37.99%
Revenue (1Y)0.50%
Earnings (1Y)-25.25%
FCF Growth (3Y)16.99%

الجودة

Return on Equity
21.45%
ROIC21.38%
Net Margin15.15%
Op. Margin20.16%

الأمان

Debt / Equity
0.00
Current Ratio2.70
Interest Coverage15.74

التقييم

P/E Ratio
21.50
P/B Ratio4.61
EV/EBITDA15.00
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 0.50% Revenue Growth (3Y) 9.05%
Earnings Growth (1Y) -25.25% Earnings Growth (3Y) -15.44%
Revenue Growth (5Y) 37.99% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1.54B Net Income (TTM) 233.56M
ROE 21.45% ROA 10.49%
Gross Margin 61.10% Operating Margin 20.16%
Net Margin 15.15% Free Cash Flow (TTM) 354.05M
ROIC 21.38% FCF Growth (3Y) 16.99%
Safety
Debt / Equity 0.00 Current Ratio 2.70
Interest Coverage 15.74 Dividend Yield 0.00%
Valuation
P/E Ratio 21.50 P/B Ratio 4.61
P/S Ratio 3.26 PEG Ratio -0.82
EV/EBITDA 15.00 Dividend Yield 0.00%
Market Cap 5.02B Enterprise Value 4.66B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.54B 1.53B 1.30B 935.06M 425.21M
Net Income 233.56M 312.44M 326.66M 28.07M -71.28M
EPS (Diluted) 3.41 4.36 4.65 0.40 -1.06
Gross Profit 941.95M 988.29M 709.54M 581.70M 187.70M
Operating Income 310.83M 456.98M 364.64M 36.20M -60.83M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2.23B 1.98B 1.65B 1.32B 863.78M
Total Liabilities 1.14B 892.33M 835.26M 874.11M 399.35M
Shareholders' Equity 1.09B 1.09B 815.89M 447.15M 464.44M
Total Debt 738,000.0 619.44M 616.95M 583.51M 191.31M
Cash & Equivalents 359.12M 912.81M 713.66M 415.65M 98.51M
Current Assets 899.96M 1.33B 1.09B 677.62M 235.79M
Current Liabilities 333.42M 240.53M 187.35M 247.70M 90.50M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#171 of 195
26

النشاط الأخير

دخل Value Investing (Warren Buffett)
Mar 24, 2026